Cancer Res Treat.  2008 Mar;40(1):1-5.

The Increasing Frequency of Cervical Cancer in Korean Women under 35

• Han CH
• Cho HJ
• Lee SJ
• Bae JH
• Bae SN
• Namkoong S
• Park JS

Abstract

PURPOSE: The goal of this study was to determine the clinical and epidemiological trends of cervical cancer in young Korean women. Social behavior including sexual habits has changed in Korean women, with sexual activity commencing at a younger age. These changes are likely to influence certain risk factors of cervical cancer, resulting in changing trends in the occurrence of the disease.
MATERIALS AND METHODS
The incidence of cervical cancer in women less than 35 years-old between January 1990 and December 2006 was analyzed, and available medical records from January 1996 to December 2006 were reviewed. The clinical, pathological and epidemiologic characteristics and changing trends among these young patients were analyzed.
RESULTS
Over the last two decades, the incidence of young (< 35 years) cervical cancer patients increased, more patients had an aggressive form of the disease, and there was a higher rate of women with more advanced education. Human papillomavirus (HPV) infection was detected in 94.0% of the women (63/67) tested. HPV 16 (82.5%) and HPV 18 (12.7%) were the two most common viral infections detected throughout the study period.
CONCLUSIONS
The changing trends and risk factors identified suggest a need for more active education of young women about cervical cancer prevention strategies. In addition, young women are strongly recommended to undergo a regular screening test and HPV vaccination.

Keyword

Uterine cervical neoplasms; Incidence; Epidemiology; Sexual behavior; Human papillomavirus (HPV); Young patients

MeSH Terms

Female
Human papillomavirus 16
Human papillomavirus 18
Humans
Incidence
Mass Screening
Medical Records
Risk Factors
Sexual Behavior
Social Behavior
Uterine Cervical Neoplasms
Vaccination

Figure

• 

  Fig. 1 Increasing proportion of patients younger than 35 years old with cervical cancer (p=0.033).

Reference

1. Lee MY, Cho CH, Kwon SH, Song DK, Chung SW, Kang HO, et al. Annual report of gynecologic cancer registry program in Korea for 2002 (Jan. 1st, 2002 - Dec. 31st, 2002). Korean J Obstet Gynecol. 2004; 47:1029–1070.

2. Kwak MS, Park EC, Bang JY, Sung NY, Lee JY, Choi KS. Factors associated with cancer screening participation, Korea. J Prev Med Pub Health. 2005; 38:473–481. PMID: 16358835.

3. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, et al. The carcinogenicity of human papil lomavirus types reflects viral evolution. Virology. 2005; 337:76–84. PMID: 15914222.

4. Kim CJ, Kim BG, Kim SC, Kim YT, Kim YM, Park SY, et al. Sexual behavior of Korean young women: Preliminary study for the introducing of HPV prophylactic vaccine. Korean J Gynecol Oncol. 2007; 18:209–218.

5. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2006; 95(Suppl 1):S43–S103. PMID: 17161167.

6. Pecorelli S, Favalli G, Zigliani L, Odicino F. Cancer in women. Int J Gynaecol Obstet. 2003; 82:369–379. PMID: 14499983.

7. Parkin DM. Cancer in developing countries. Cancer Surv. 1994; 19-20:519–561. PMID: 7534640.

8. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55:74–108. PMID: 15761078.

9. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997; 102:3–8. PMID: 9217656.

10. Jung WW, Chun T, Sul D, Hwang KW, Kang HS, Lee DJ, et al. Strategies against human papillomavirus infection and cervical cancer. J Microbiol. 2004; 41:255–266. PMID: 15650698.

11. Park TC, Kim CJ, Koh YM, Lee KH, Yoon JH, Kim JH, et al. Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol. 2004; 23:119–125. PMID: 15000752.

12. Bae JH, Lee SJ, Kim CJ, Hur SY, Park YG, Lee WC, et al. Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol. 2008; 4. [in press].

13. Becker TM, Wheeler CM, McGough NS, Parmenter CA, Jordan SW, Stidley CA, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA. 1994; 271:1181–1188. PMID: 8151876.

14. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer. 2003; 103:413–421. PMID: 12471626.

15. International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 2007; 120:885–891. PMID: 17131323.

16. Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, et al. Sexual behavior in contest: a global perspective. Lancet. 2006; 368:1706–1728. PMID: 17098090.

17. Chung HH, Jang MJ, Jung KW, Won YJ, Shin HR, Kim JW, et al. Cervical cancer incidence and survival in Korea : 1993-2002. Int J Gynecol Cancer. 2006; 16:1833–1838. PMID: 17009979.

18. Atahan IL, Onal C, Ozyar E, Yiliz F, Selek U, Kose F. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int J Gynecol Cancer. 2007; 17:833–842. PMID: 17367320.

19. Kastritis E, Bamia A, Bozas G, Koutsoukou V, Voulgaris Z, Vlahos G, et al. The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy. Gynecol Oncol. 2000; 104:372–376. PMID: 17030353.

20. Russell JM, Blair V, Hunter RD. Cervical carcinoma: prognosis in younger patients. Br Med J. 1987; 295:300–303. PMID: 3115418.

21. Mariani L, Iacovelli A, Vincenzoni C, Diotallevi FF, Atlante M, Lambardi A. Cervical carcinoma in young patients: clinical and pathological variables. Int J Gynaecol Obstet. 1993; 41:61–66. PMID: 8098297.

22. Murrell DS, Helm CW, Bourne H. Carcinoma of the cervix in women up to 35 year of age. Clinical Oncol. 1990; 2:260–263.

23. Elliott PM, Tattersall MH, Coppleson M, Russel P, Wong F, Coates AS, et al. Changing character of cervical cancer in young women. BMJ. 1989; 298:288–290. PMID: 2493898.

24. Vinh-Hung V, Bourgain C, Vlastos G, Cserni G, De Ridder M, Storme G, et al. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer. 2007; 7:164. PMID: 17718897.

25. Kirschner B, Simonsen K, Junge J. Comparison of convertntional Papanicolaou smear and SurePath liquid-based cytology in the Copenhagen population screening programme for cervical cancer. Cytopathology. 2006; 17:187–194. PMID: 16879266.